文献速递肝病

多囊卵巢综合征伴高雄激素血症是非肥胖非酒精性脂肪性肝病的危险因素

Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.
PubMed 文献 · Aliment Pharmacol Ther · 2017-03-30

本研究为病例对照研究,纳入275例非肥胖多囊卵巢综合征(PCOS)女性和892例非肥胖对照,比较非酒精性脂肪性肝病(NAFLD)患病率。PCOS组NAFLD患病率显著高于对照组(5.5% vs 2.8%,P=0.027),校正年龄和BMI后PCOS与NAFLD独立相关(OR 2.62,95%CI 1.25-5.48)。在PCOS女性中,游离睾酮或游离雄激素指数代表的雄激素水平与NAFLD独立相关。

要点

  • 非肥胖PCOS女性NAFLD患病率显著高于非肥胖对照(5.5% vs 2.8%,P=0.027)。
  • 校正年龄和BMI后,PCOS与NAFLD独立相关(OR 2.62,95%CI 1.25-5.48)。
  • PCOS女性中,游离睾酮或游离雄激素指数与NAFLD独立相关。

核心结论

  • 非肥胖女性中,PCOS患者NAFLD患病率高于无PCOS者。
  • 非肥胖PCOS患者中,高雄激素血症可能是非肥胖NAFLD的独立危险因素。

研究设计与样本

  • 病例对照研究,使用前瞻性PCOS队列。
  • 排除其他潜在慢性肝病原因后,纳入275例非肥胖PCOS女性和892例非肥胖对照。
  • NAFLD通过肝脏超声诊断。

主要发现

  • 非肥胖PCOS女性NAFLD患病率显著高于非肥胖对照(5.5% vs 2.8%,P=0.027)。
  • 校正年龄和BMI后,PCOS与NAFLD相关(OR 2.62,95%CI 1.25-5.48)。
  • PCOS女性中,校正年龄、BMI、血脂谱、胰岛素抵抗或血糖状态后,游离睾酮或游离雄激素指数代表的雄激素水平与NAFLD相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is known to be associated with polycystic ovary syndrome (PCOS). However, most studies investigated the prevalence of NAFLD in obese PCOS patients. AIM: To compare the prevalence of non-obese NAFLD in women with or without PCOS, and to assess an independent association between PCOS and NAFLD in a non-obese Asian cohort. METHODS: This was a case-control study using a prospective PCOS cohort. After subjects with other potential causes of chronic liver disease were excluded, 275 non-obese women with PCOS and 892 non-obese controls were enrolled. NAFLD was determined by hepatic ultrasonography. Main outcomes were the prevalence of NAFLD on hepatic ultrasonography between non-obese women with or without PCOS, and an independent association between non-obese NAFLD and PCOS. RESULTS: Non-obese women with PCOS had a significantly higher prevalence of NAFLD than those without PCOS (5.5% vs. 2.8%, P = 0.027). PCOS was associated with non-obese NAFLD (odds ratio: 2.62, 95% confidence intervals: 1.25-5.48) after adjustment for age and body mass index (BMI). In women with PCOS, the level of androgenicity represented by free testosterone or free androgen index was associated with NAFLD after adjustment for age, BMI, lipid profile, insulin resistance or glycaemic status. CONCLUSIONS: Non-obese NAFLD is more prevalent in women with polycystic ovary syndrome than in those without. In non-obese patients with polycystic ovary syndrome, hyperandrogenemia may be an independent risk factor for non-obese NAFLD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Kim JJ, Kim D, Yim JY, et al. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017. PMID: 28370150. doi:10.1111/apt.14058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。